Talha Badar/X
Apr 1, 2025, 07:29
Talha Badar: Predictors of CNS relapse in APL
Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared an article by Bingqian Jiang, et al. on X:
“Predictors of CNS relapse in APL:
- Incidence 1.4%.
- Majority of these pts had FLT3 mutation or intracranial hemorrhage at diagnosis/during induction.
- Median time to CNS relapse 22 mo.
- No difference in incidence with or without anthracycline based induction.”
Characteristics and predictors of central nervous system relapse in newly diagnosed acute promyelocytic leukemia in the era of arsenic: a 13-year monocenter cohort study.
Authors: Bingqian Jiang, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53
Apr 1, 2025, 11:51